🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

Charles River Laboratories and Labcorp shares fall on potential NHP supply issues

Published 11/30/2022, 01:27 PM
Updated 11/30/2022, 01:30 PM
© Reuters.  Charles River Laboratories and Labcorp shares fall on potential NHP supply issues
LH
-
CRL
-

By Sam Boughedda

Shares of Laboratory Corporation of America Holdings (NYSE:LH) and Charles River Laboratories (NYSE:CRL) dipped Wednesday in relation to the ability of the companies to obtain Cambodia-sourced non-human primates.

The concerns relate to a November 16 announcement by the U.S. Department of Justice that a Cambodian NHP supplier and two Cambodian officials had been criminally charged in connection with illegally importing NHPs into the United States.

Charles River Laboratories commented on the topic in an SEC filing today, suggesting the supply of Cambodia-sourced NHPs will be difficult to obtain in the United States "for some time." They made the statement in light of the indictment and subsequent statements made by the Cambodian government.

However, CRL made clear that it was not named or referenced in the DOJ proceedings and does not have any direct supply contracts with the indicted Cambodian supplier.

If it is the case that NHPs will be difficult to obtain in the U.S. for some time, then Labcorp could also be impacted.

Labcorp shares are currently down 2.74%, while CRL has declined 7.5%.

CRL added that it is currently working to mitigate any Cambodia NHP supply impact with efforts to procure NHPs under different supply arrangements.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.